Vernon Sondak

21PUBLICATIONS
184CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Engineering electromagneticsCancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jun 23, 2026
Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy.

|May 20, 2025
Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-risk Melanoma.

Ahmad A Tarhini, Alyssa Obermayer, Sandra J Lee

|Oct 17, 2024
Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma.

Ahmad A Tarhini, Zeynep Eroglu, Islam Eljilany

|Oct 04, 2024
Evaluation and Surgical Management of Pediatric Cutaneous Melanoma and Atypical Spitz and Non-Spitz Melanocytic Tumors (Melanocytomas): A Report From Children's Oncology Group.

Michael R Sargen, Raymond L Barnhill, David E Elder

|Sep 29, 2024
Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanoma.

Christopher D Lao, James Moon, Vincent T Ma

|Jul 26, 2024
Preexisting Skin-Resident CD8 and γδ T-cell Circuits Mediate Immune Response in Merkel Cell Carcinoma and Predict Immunotherapy Efficacy.

Zachary Z Reinstein, Yue Zhang, Oscar E Ospina

Pageof 4

Frequent Collaborators

8 joint publications

Nikhil I Khushalani

6 joint publications

Jane Messina

5 joint publications

John M Kirkwood

5 joint publications

Ahmad A Tarhini